CA Stock MarketDetailed Quotes

AGN Algernon Pharmaceuticals Inc

Watchlist
  • 0.075
  • +0.005+7.14%
15min DelayMarket Closed Dec 13 15:59 ET
2.05MMarket Cap-2.21P/E (TTM)

Algernon Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-206.21%-1.2M
-19.52%1M
-72.24%521.97K
-12.92%5.24M
-54.80%985.85K
40.80%1.13M
-32.06%1.25M
56.56%1.88M
-25.23%6.02M
299.45%2.18M
Selling and administrative expenses
-46.64%356.12K
-42.54%665.2K
-76.75%354.4K
11.28%4.15M
-41.64%797.49K
-6.51%667.45K
8.02%1.16M
165.39%1.52M
14.52%3.73M
81.40%1.37M
-Selling and marketing expense
-80.74%29.95K
-86.89%40.55K
-81.87%104.86K
72.75%1.26M
-35.93%217.7K
26.41%155.55K
148.79%309.16K
305.26%578.3K
-8.12%729.8K
44.64%339.78K
-General and administrative expense
-36.28%326.17K
-26.39%624.65K
-73.62%249.54K
-3.69%2.89M
-43.53%579.79K
-13.37%511.91K
-10.44%848.58K
119.15%945.86K
21.83%3M
98.06%1.03M
Research and development costs
-437.45%-1.55M
276.45%339.01K
-52.95%167.58K
-52.25%1.1M
-76.88%188.36K
427.98%460.58K
-88.22%90.06K
-43.17%356.17K
-52.19%2.29M
493.11%814.69K
Operating profit
206.21%1.2M
19.52%-1M
72.24%-521.97K
12.92%-5.24M
54.80%-985.85K
-40.80%-1.13M
32.06%-1.25M
-56.56%-1.88M
25.23%-6.02M
-299.45%-2.18M
Net non-operating interest income (expenses)
-48.23%380
0.00%308
42.86%420
0.91%2.1K
64.01%761
33.45%734
-48.58%308
-36.77%294
-82.58%2.08K
-28.83%464
Non-operating interest income
-48.23%380
0.00%308
42.86%420
0.91%2.1K
64.01%761
33.45%734
-48.58%308
-36.77%294
-82.58%2.08K
-28.83%464
Other net income (expenses)
245.46K
-4,125.19%-1.54M
-111.96%-36.48K
Special income (charges)
--245.46K
----
----
-4,125.19%-1.54M
---1.54M
--0
----
----
---36.48K
----
-Less:Impairment of capital assets
----
----
----
4,125.19%1.54M
----
----
----
----
--36.48K
----
-Less:Other special charges
---245.46K
----
----
----
----
----
----
----
----
----
Income before tax
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
Income tax
Earnings from equity interest net of tax
Net income
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
Net income continuous operations
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
Noncontrolling interests
Net income attributable to the company
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
Diluted earnings per share
170.00%0.07
61.54%-0.05
85.00%-0.03
48.28%-0.45
44.78%-0.1601
16.67%-0.1
51.85%-0.13
-32.62%-0.2
16.43%-0.87
-4,514.89%-0.29
Basic earnings per share
160.00%0.06
61.54%-0.05
85.00%-0.03
48.28%-0.45
44.78%-0.1601
16.67%-0.1
51.85%-0.13
-32.62%-0.2
16.43%-0.87
-4,514.89%-0.29
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -206.21%-1.2M-19.52%1M-72.24%521.97K-12.92%5.24M-54.80%985.85K40.80%1.13M-32.06%1.25M56.56%1.88M-25.23%6.02M299.45%2.18M
Selling and administrative expenses -46.64%356.12K-42.54%665.2K-76.75%354.4K11.28%4.15M-41.64%797.49K-6.51%667.45K8.02%1.16M165.39%1.52M14.52%3.73M81.40%1.37M
-Selling and marketing expense -80.74%29.95K-86.89%40.55K-81.87%104.86K72.75%1.26M-35.93%217.7K26.41%155.55K148.79%309.16K305.26%578.3K-8.12%729.8K44.64%339.78K
-General and administrative expense -36.28%326.17K-26.39%624.65K-73.62%249.54K-3.69%2.89M-43.53%579.79K-13.37%511.91K-10.44%848.58K119.15%945.86K21.83%3M98.06%1.03M
Research and development costs -437.45%-1.55M276.45%339.01K-52.95%167.58K-52.25%1.1M-76.88%188.36K427.98%460.58K-88.22%90.06K-43.17%356.17K-52.19%2.29M493.11%814.69K
Operating profit 206.21%1.2M19.52%-1M72.24%-521.97K12.92%-5.24M54.80%-985.85K-40.80%-1.13M32.06%-1.25M-56.56%-1.88M25.23%-6.02M-299.45%-2.18M
Net non-operating interest income (expenses) -48.23%3800.00%30842.86%4200.91%2.1K64.01%76133.45%734-48.58%308-36.77%294-82.58%2.08K-28.83%464
Non-operating interest income -48.23%3800.00%30842.86%4200.91%2.1K64.01%76133.45%734-48.58%308-36.77%294-82.58%2.08K-28.83%464
Other net income (expenses) 245.46K-4,125.19%-1.54M-111.96%-36.48K
Special income (charges) --245.46K---------4,125.19%-1.54M---1.54M--0-----------36.48K----
-Less:Impairment of capital assets ------------4,125.19%1.54M------------------36.48K----
-Less:Other special charges ---245.46K------------------------------------
Income before tax 228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M
Income tax
Earnings from equity interest net of tax
Net income 228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M
Net income continuous operations 228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M
Noncontrolling interests
Net income attributable to the company 228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M
Diluted earnings per share 170.00%0.0761.54%-0.0585.00%-0.0348.28%-0.4544.78%-0.160116.67%-0.151.85%-0.13-32.62%-0.216.43%-0.87-4,514.89%-0.29
Basic earnings per share 160.00%0.0661.54%-0.0585.00%-0.0348.28%-0.4544.78%-0.160116.67%-0.151.85%-0.13-32.62%-0.216.43%-0.87-4,514.89%-0.29
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data